Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) FCF Margin (2019 - 2023)

Historic FCF Margin for ADC Therapeutics (ADCT) over the last 5 years, with Q3 2023 value amounting to 257.6%.

  • ADC Therapeutics' FCF Margin fell 2576000.0% to 257.6% in Q3 2023 from the same period last year, while for Dec 2023 it was 231.02%, marking a year-over-year decrease of 2308200.0%. This contributed to the annual value of 66218.53% for FY2022, which is N/A changed from last year.
  • Per ADC Therapeutics' latest filing, its FCF Margin stood at 257.6% for Q3 2023, which was down 2576000.0% from 187.73% recorded in Q2 2023.
  • Over the past 5 years, ADC Therapeutics' FCF Margin peaked at 0.0% during Q3 2022, and registered a low of 445637.79% during Q3 2021.
  • Its 5-year average for FCF Margin is 40439.31%, with a median of 137.06% in 2023.
  • Per our database at Business Quant, ADC Therapeutics' FCF Margin skyrocketed by 2000000000bps in 2022 and then tumbled by -2576000bps in 2023.
  • Over the past 5 years, ADC Therapeutics' FCF Margin (Quarter) stood at 15159.91% in 2019, then plummeted by -43bps to 21690.54% in 2020, then plummeted by -1955bps to 445637.79% in 2021, then soared by 100bps to 0.2% in 2022, then crashed by -129976bps to 257.6% in 2023.
  • Its last three reported values are 257.6% in Q3 2023, 187.73% for Q2 2023, and 86.39% during Q1 2023.